Brainstorm Cell Therapeutics, Inc. (BCLI)
0.75
+0.03
(+4.02%)
USD |
OTCM |
May 29, 16:00
Brainstorm Cell Therapeutics Shareholders Equity (Quarterly) : -11.01M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| NovelStem International Corp. | -1.947M |
| Summit Therapeutics, Inc. | 545.93M |
| Kezar Life Sciences, Inc. | 65.24M |
| Protara Therapeutics, Inc. | 181.21M |
| Clene, Inc. | -18.81M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.755M |
| Total Liabilities (Quarterly) | 11.76M |
| Debt to Equity Ratio | -0.1352 |
| Current Ratio | 0.0156 |
| Net Debt Paydown Yield | -0.89% |